The Veteran's prostate cancer rating was reduced from 100% to 40%, effective June 1, 2020. The reduction was improper and the 100% rating is restored.,Service connection for PTSD was granted with an effective date of April 11, 2012, but no earlier.,SMC pursuant to 38 U.S.C. § 1114(s) from June 1, 2020, is granted.,SMC due to loss of use of a creative organ from December 12, 2019, is denied.,An initial compensable rating for erectile dysfunction is granted and an effective date earlier than December 12, 2019 is sought.,A higher rating for type II diabetes mellitus is requested.
The deciding factor: The reduction in the prostate cancer rating was improper due to inadequate notice of the proposed reduction, leading to restoration of the original 100% rating.
- Claimed conditions
- Prostate cancer, Type II diabetes mellitus, Erectile dysfunction, Posttraumatic stress disorder (PTSD)
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- November 16, 2022
- Citation
- A22023212
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A22023212.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran is granted special monthly compensation (SMC) at the (o) rate and SMC at the (r)(2) rate, effective January 19, 2025. The decision finds that the Veteran's service-connected conditions warrant these awards due to his need for aid and attendance.
- Granted
The Board has granted the Veteran's claim for compensation under 38 U.S.C. § 1151 for residuals of prostate cancer due to VA's failure to notify him of his April 17, 2008, elevated PSA test results and its failure to timely diagnose and properly treat his disease.
- Remanded (sent back)
The Board has remanded the claims for further development due to insufficient evidence and need for additional examinations.
- Granted
The Veteran's arteriosclerotic heart disease is rated at 100% effective October 25, 2024. His prostate cancer residuals are rated at 60% effective October 25, 2024.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.